A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair

被引:105
作者
Amanat, N
Brown, R
Bilston, LE
Little, DG
机构
[1] Childrens Hosp, Westmead, NSW 2145, Australia
[2] Univ Sydney, Sch Aerosp Mech & Mech Engn, Sydney, NSW 2006, Australia
[3] Prince Wales Med Res Inst, Sydney, NSW 2052, Australia
[4] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia
[5] Univ Sydney, Dept Pediat & Child Hlth, Sydney, NSW 2006, Australia
关键词
bisphosphonates; fracture healing; biomechanical testing; osteotomy; local delivery;
D O I
10.1016/j.orthres.2005.03.004
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Complications in fracture repair that lead to a delay in union remain clinically problematic. We believe that unwanted pre-mature catabolism of the healing callus, for example, in stress shielded situations, diminishes the rate at which strength is restored in bone repair and possibly leads to delayed union. We hypothesized that a single systemic dose of a nitrogen-containing bisphosphonate (N-BP) would increase bone mineral content (BMC), volume, and mechanical strength of union in fracture repair. We also set out to investigate local delivery to assess whether systemic exposure could be eliminated, due to concerns of bisphosphonate dosing of nontarget organs. After an open osteotomy fixed with a K wire, 40 12-week old Wistar male rats were divided into four groups of 10: saline control, bolus systemic subcutaneous injection of pamidronate (3 mg/kg), local low dose of pamidronate (0.1 mg), and a local high dose of pamidronate (1.0 mg). Rats were sacrificed 6 weeks post-operatively. Operated and non-operated femora underwent radiographic evaluation, quantitative computer tomography, and biomechanical testing in torsion. The growth plates and metaphyses of the tibia of the non-operated side were assessed for evidence of systemic exposure in the local groups. Significant increases in callus BMC and volume of the bolus systemic dose group were found compared to the saline control (p <= 0.05). Further, the strength of the systemic dose callus was increased by 60% from 0.35 Nm (+/- 0.11) for the saline control callus to 0.56 Nm (+/- 0.25) for the systemic group (p = 0.05). Local treatment did not result in increased strength. The contralateral tibial growth plates of the local groups showed evidence of systemic exposure by the presence of retained primary spongiosa. This study confirms that a single perioperative systemic dose of pamidronate leads to significant increases in the BMC, volume, and strength of healing fractures in rats, making single dose N-BP therapy an appealing candidate for further examination in fracture repair. (c) 2005 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 23 条
[1]   Clodronate increases mineralization of callus after Colles' fracture -: A randomized, double-blind, placebo-controlled, prospective trial in 32 patients [J].
Adolphson, P ;
Abbaszadegan, H ;
Bodén, H ;
Salemyr, M ;
Henriques, T .
ACTA ORTHOPAEDICA SCANDINAVICA, 2000, 71 (02) :195-200
[2]   Biphosphonates [J].
Allgrove, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (01) :73-75
[3]   Profiling the safety and tolerability of bisphosphonates [J].
Body, JJ ;
Diel, I ;
Bell, R .
SEMINARS IN ONCOLOGY, 2004, 31 (05) :73-78
[4]   Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta [J].
Evans, KD ;
Lau, ST ;
Oberbauer, AM ;
Martin, RB .
BONE, 2003, 32 (03) :268-274
[5]   Can bisphosphonates be given to patients with fractures? [J].
Fleisch, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (03) :437-440
[6]  
Fleisch H., 1995, BISPHOSPHONATES BONE
[7]   Cyclic administration of pamidronate in children with severe osteogenesis imperfecta [J].
Glorieux, FH ;
Bishop, NJ ;
Plotkin, H ;
Chabot, G ;
Lanoue, G ;
Travers, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :947-952
[8]  
Goodship A E, 1994, Ann Oncol, V5 Suppl 7, pS53
[9]  
Kenwright J, 1998, CLIN ORTHOP RELAT R, pS179
[10]  
Kumar D, 2004, BONE, V34, pS60